Clinical pharmacists participating in the analysis of drug therapy for a case of Bartonella henselae meningitis
10.12173/j.issn.1005-0698.202305032
- VernacularTitle:临床药师参与1例汉赛巴尔通体脑膜炎的药物治疗分析
- Author:
Tingting PENG
1
;
Ruixi YANG
;
Hong NING
;
Yalan TIAN
Author Information
1. 电子科技大学医学院附属绵阳医院·绵阳市中心医院药学部(四川绵阳 621000)
- Keywords:
Bartonella henselae meningitis;
Anti-infective therapy;
Pharmaceutical care
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(1):106-110
- CountryChina
- Language:Chinese
-
Abstract:
Clinical pharmacists participated in the anti-infection treatment of a patient with Bartonella henselae meningitis.According to the clinical manifestations and the quantitative metagenomic second-generation sequencing(mNGS)of cerebrospinal fluid,the patient was diagnosed as Bartonella henselae infection.According to the relevant clinical guidelines and foreign case treatment reports,it is recommended to use minocycline hydrochloride capsule oral treatment combined with rifampicin injection.Follow-up treatment of the patient was dynamically adjusted based on the reexamination results of cerebrospinal fluid and related inflammatory indicators.In the treatment process,clinical pharmacists give full play to their professional expertise,provide the patient with individualized pharmaceutical care,optimize anti-infection programs,and further promote clinical rational drug use.
